Fecal Transplant Overcomes Nivolumab Resistance in Melanoma
In a miniature scientific trial, fecal transplants restored the response to immunotherapy in 3 of 10 patients with refractory metastatic melanoma whose prerequisites had stopped responding to therapy with anti–programmed cell death–ligand-1 (anti-PD-LI) treatment. One in all these patients had…